DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20193784

A cross sectional study to determine polycystic ovarian disease among students of a tertiary care teaching hospital

Raja Sekhar Jalemu, Kasthuribai Sabbe, Grishma Jalemu

Abstract


Background: India now has highest number of patients with type 2 diabetes mellitus globally and speedy rise of the incidence of obesity in children is the major reason for increasing insulin resistance, the metabolic syndrome, dyslipidemia and polycystic ovarian syndrome. But proportion for PCOD is unknown in community. Objective of this study was to estimate the prevalence of PCOD among students in Tertiary care teaching hospital.

Methods: A cross sectional study was conducted among students of aged 16-24 years in a teaching hospital in Kerala. Sample sizes of 256 students were randomly selected from various batches of medical and paramedical courses. Occurrence of hyper androgenic features and menstrual irregularities were evaluated, and they were physically examined. The diagnosis of PCOS was made based on Rotterdam’s criteria. Epi-info 7 was used for analysis.

Results: Seventy-five students (30%) met the criteria to be diagnosed as polycystic ovarian syndrome. Twenty students (10%) had a history of thyroid dysfunction. The other clinical features of hyperandrogenism were like acne (25%), oily skin (13.5%), and increased hair growth (7%), male pattern thinning of hair (9.75%).

Conclusions: PCOD can be assumed of as a forerunner syndrome that, if screened for, can help in early identification of risk of highly morbid conditions, in adolescent girls.


Keywords


Acne, Adolescent, Hyper androgens, Menstrual irregularities, Metabolic syndrome, PCOD, Risk factors

Full Text:

PDF

References


Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008;139(1):59-64.

Michelmore KF, Balen AH, Dunger DB. Polycystic ovaries and associates; clinical and biochemical features in young women. Clin Endocrinol. 1999;51:779.

Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434-8.

Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):36-42.

Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235-44.

Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007;47(3):412-7.

Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369-76.

List of goals, targets, and indicators. Available at: www.worldbank.org.

Kumarapeli V, Seneviratne RD, Wijeyaratne CN. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008;168:321.

Deswal R, Dang AS. Prevalence of poly cystic ovary syndrome (PCOS) in North Indian Women. Indian J Health Well-being. 2014;5(6):742-4.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril. 2004;81(1):19-25.

Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685-97.

Esmaeilzadeh S, Delavar MA, Amiri M, Khafri S, Pasha NG. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health. 2014;26(4):559-65.

Bindu BR. Increasing incidence of PCOS in adolescence and its relation with mental Stress. Res J Recent Sci. 2014;3(ISC-2013);227-30.

Carmina E, Lobo RA. Polycystic ovaries in hirsute women with normal menses. 2001;111(8):602-6.

Carey AH, Chan KL, Short F. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf). 1993;38(6):653-8.

Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95(25):14956-60.

Giudice LC. Endometrium in PCOS: Implantation andpredisposition to endocrine CA. Best Pract Res Clin

EndocrinolMetab. 2006;20(2):235–44.

Cerda C, Perez-Ayuso RM, Riquelme A, Soza A,Villaseca P, Sir-Petermann T. Nonalcoholic fatty liver

disease in women with polycystic ovary syndrome. JHepatol. 2007;47(3):412–7.

Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ,Dokras A. Increased risk of depressive disorders in

women with polycystic ovary syndrome. FertilSteril.2007;87(6):1369–76.

"List of goals, targets, and indicators". Available fromwww.worldbank.org. Retrieved. 2012-10-18.

Kumarapeli, V., Seneviratne, R.D., Wijeyaratne, C.N. Asimple screening approach for assessing communityprevalence and phenotype of polycystic ovary syndromein a semi-urban population in Sri Lanka. Am J Epidemiol.2008;168:321.

RituDeswal, AmitaSuneja Dang. Prevalence of PolyCystic Ovary Syndrome (PCOS) in North Indian Women- Indian journal of health and well-being.2014;5(06):742-744.

Rotterdam ESHRE/ASRM-Sponsored PCOS ConsensusWorkshop Group. FertilSteril. 2004;81(1):19-25.

Norman RJ, Dewailly D, Legro RS, Hickey TE; Lancet.2007;370(9588):685-9.

Esmaeilzadeh S, Delavar MA, Amiri M, Khafri S, PashaNG. Polycystic ovary syndrome in Iranian adolescents.Int J Adolesc Med Health. 2014;26(4):559-65.

Bindu B.R. Increasing Incidence of PCOS inAdolescence and its relation with mental Stress. Research

Journal of Recent Sciences. 2014;3(ISC-2013);227-230.

Enrico Carmina, Rogerio A Lobo. Polycystic ovaries inhirsute women with normal menses. 2001;111(8):602-606.

Carey, A.H., Chan, K.L., Short, F. Evidence for a singlegene effect causing polycystic ovaries and male patternbaldness. ClinEndocrinol (Oxf). 1993;38(6):653-8.

Legro RS, Driscoll D, Strauss JF 3rd, Fox J, Dunaif A.Evidence for a genetic basis for hyperandrogenemia inpolycystic ovary syndrome. ProcNatlAcadSci U S A.1998;95(25):14956-60